Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA First Amendment Plan: Series Of Guidances Rather Than Omnibus Rule

Executive Summary

FDA's policy on regulating commercial speech will be addressed through a series of guidances and rules related to specific areas of interest
Advertisement

Related Content

FDA Advertising Policy Adopts FTC’s “Reasonable Consumer” Standard
FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged
IG Pharma Compliance Guide Has First Amendment Flaws, Attorney Says
IG Pharma Compliance Guide Has First Amendment Flaws, Attorney Says
Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count
Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count
FDA DTC Stance Is “Ideological,” Not Science-Based, Rep. Waxman Says
DTC Guidance Is High Priority In First Amendment Review, FDA Says
DTC Guidance Is High Priority In First Amendment Review, FDA Says
Flonase DTC Ads Highlight Formulary Status Versus Antihistamines
Advertisement
UsernamePublicRestriction

Register

PS041430

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel